Related Experiment Video

Updated: Aug 29, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

[Pharmacological consequences of the targeting of epidermal growth factor receptor]

Gérard Milano1, Nicolas Magné

  • 1Laboratoire d'oncopharmacologie, Centre Antoine-Lacassagne, 33, avenue de Valombrose, 06189 Nice. gerard.milano@nice.fnclcc.fr

Bulletin Du Cancer
|February 7, 2004
PubMed

Insights

Epidermal growth factor receptor (EGFR) targeting modifies cell functions, supporting combined therapies. Further research is needed on drug sequencing, EGFR expression, and resistance mechanisms for optimal clinical use.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Epidermal growth factor receptor (EGFR) targeting influences cancer cell proliferation, apoptosis, and DNA repair.
  • EGFR targeting drugs are utilized in combination with cytotoxic agents like chemotherapy and radiotherapy.
  • Clinical trials are investigating combinations of EGFR targeting agents and anticancer drugs.

Purpose of the Study:

  • To explore the impact of drug sequencing on combination therapy efficacy.
  • To investigate the influence of tumoral EGFR expression levels on combination treatment outcomes.
  • To address the knowledge gap regarding resistance mechanisms to EGFR targeting agents.

Main Methods:

  • Review of experimental studies and clinical trials involving EGFR targeting agents.
  • Analysis of molecular mechanisms underlying EGFR signaling pathways.
  • Examination of data on combination therapies with cytotoxic agents.

Main Results:

  • EGFR targeting demonstrates clear molecular mechanisms affecting cell physiology, justifying its use in combination therapies.
  • Existing data highlight the potential of combining EGFR inhibitors with cytotoxic treatments.
  • Significant gaps exist in understanding the role of drug sequence and EGFR expression in treatment response.

Conclusions:

  • While EGFR targeting shows promise, optimal clinical development requires further investigation into sequencing, EGFR expression impact, and resistance mechanisms.
  • Understanding these factors is crucial for refining combination strategies and improving patient outcomes in EGFR-targeted cancer therapy.

More Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...